Literature DB >> 20698049

Germline mutation analysis of hPMS2 gene in Chinese families with hereditary nonpolyposis colorectal cancer.

Xia Sheng1, Heng-Hua Zhou, Xiao-Yan Zhou, Xiang Du, Tai-Ming Zhang, San-Jun Cai, Wei-Qi Sheng, Da-Ren Shi.   

Abstract

AIM: To study the germline mutation of hPMS2 gene in 26 unrelated Chinese hereditary nonpolyposis colorectal cancer (HNPCC) probands and to fulfill the screening strategy for HNPCC in Chinese.
METHODS: Genomic DNA was extracted from the peripheral blood. To avoid the interference of pseudogene in detection of the remaining 11 exons (exon 1-5, 9, 11-15), long-range polymerase chain reaction (PCR) was conducted to amplify the complete coding region of hPMS2 gene firstly. Then 1/8 of the PCR products were used as template to amplify the individual exon respectively and DNA sequencing was done. Direct DNA sequencing of the conventional PCR products of exon 6, 7, 8 and 10 of hPMS2 gene was performed. The same analysis was made in 130 healthy persons without family histories of HNPCC to further investigate the pathological effects of the detected missense mutation.
RESULTS: One HNPCC proband fulfilled Bethesda guidelines and was found to carry the germline mutation of hPMS2 gene, which has not been reported in Chinese HNPCC families. It was a missense mutation at c.1532C>T of exon 11. It was detected in three controls as well with an occurrence rate of 2.3% (3/130). Since it could not be found in the PMS2-single nucleotide polymorphism (SNP) database, this missense mutation is a new SNP unreported up to date. Meanwhile, 260 reported SNPs of hPMS2 gene were detected in the 26 HNPCC probands. The 2nd and 5th exons were probably the hot SNP regions of hPMS2 gene in Chinese HNPCC families involving 53.1% of all reported SNP.
CONCLUSION: The germline mutation of hPMS2 gene may be rare in Chinese HNPCC families. The 2nd and 5th exons are hot SNP regions of hPMS2 gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698049      PMCID: PMC2921098          DOI: 10.3748/wjg.v16.i30.3847

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer.

Authors:  P Peltomäki; H F Vasen
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC.

Authors:  S Fujita; Y Moriya; K Sugihara; T Akasu; K Ushio
Journal:  Jpn J Clin Oncol       Date:  1996-10       Impact factor: 3.019

3.  Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families.

Authors:  Q Cai; M H Sun; H F Lu; T M Zhang; S J Mo; Y Xu; S J Cai; X Z Zhu; D R Shi
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  [Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families].

Authors:  Qi Cai; Meng-hong Sun; Gang Fu; Chun-wei Ding; Shan-jing Mo; San-jun Cai; Shuang-xi Ren; Da-liu Min; Xiao-li Xu; Wei-ping Zhu; Tai-ming Zhang; Da-ren Shi
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2003-08

5.  Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.

Authors:  Hidewaki Nakagawa; Janet C Lockman; Wendy L Frankel; Heather Hampel; Kelle Steenblock; Lawrence J Burgart; Stephen N Thibodeau; Albert de la Chapelle
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

6.  Frequency of familial colorectal cancer.

Authors:  B M Stephenson; P J Finan; J Gascoyne; F Garbett; V A Murday; D T Bishop
Journal:  Br J Surg       Date:  1991-10       Impact factor: 6.939

7.  PMS2 involvement in patients suspected of Lynch syndrome.

Authors:  Renée C Niessen; Jan H Kleibeuker; Helga Westers; Paul O J Jager; Dennie Rozeveld; Krista K Bos; Wytske Boersma-van Ek; Harry Hollema; Rolf H Sijmons; Robert M W Hofstra
Journal:  Genes Chromosomes Cancer       Date:  2009-04       Impact factor: 5.006

8.  Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.

Authors:  E Thompson; C J Meldrum; R Crooks; M McPhillips; L Thomas; A D Spigelman; R J Scott
Journal:  Clin Genet       Date:  2004-03       Impact factor: 4.438

9.  Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.

Authors:  Shan-Run Liu; Bo Zhao; Zhen-Jun Wang; Yuan-Lian Wan; Yan-Ting Huang
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

10.  Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.

Authors:  N C Nicolaides; N Papadopoulos; B Liu; Y F Wei; K C Carter; S M Ruben; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

View more
  5 in total

1.  Lynch Syndrome Associated With PMS2 Mutation: Understanding Current Concepts.

Authors:  Shuchi Gulati; Shanna Gustafson; Hamed A Daw
Journal:  Gastrointest Cancer Res       Date:  2011-09

2.  Polymorphisms of mismatch repair gene hMLH1 and hMSH2 and risk of gastric cancer in a Chinese population.

Authors:  Xian-Qiu Xiao; Wei-DA Gong; Shi-Zhi Wang; Zheng-Dong Zhang; Xiao-Ping Rui; Guo-Zhong Wu; Feng Ren
Journal:  Oncol Lett       Date:  2011-12-06       Impact factor: 2.967

Review 3.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.

Authors:  Ying-Erh Chen; Sung-Shuo Kao; Ren-Hua Chung
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

5.  Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry.

Authors:  Zhijun Zeng; Qijia Yan; Guodong Chen; Xiaoli Zhang; Jia Huang; Kai Fu; Xiuda Peng; Shuai Xiao
Journal:  Eur J Cancer Prev       Date:  2021-05-01       Impact factor: 2.164

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.